Back to 
Comerica Bank
Comerica Bank
DSGN
Showing 0 of 2 quarters
Position history for Comerica Bank's holdings in Design Therapeutics, Inc.
No. Comerica Bank exited its DSGN (Design Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 549 shares worth $1,296. Comerica Bank first reported DSGN in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DSGN: Citadel Advisors LLC, RA Capital Management, L.P., Point72 Asset Management, L.P.